PUBLISHER: Grand View Research | PRODUCT CODE: 1363030
PUBLISHER: Grand View Research | PRODUCT CODE: 1363030
The global collagen dressing market size is anticipated to reach USD 570.06 million by 2030, according to a new report by Grand View Research, Inc.. It is anticipated to expand at a CAGR of 4.96% from 2023 to 2030. This can be attributed primarily to the increase in the number of people suffering from various chronic disorders such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. For instance, according to the Agency for Healthcare Research and Quality, every year, more than 2.5 million U.S. residents suffer from pressure ulcers. These are associated with serious infections; therefore, the use of collagen dressing is expected to increase over the forecast duration.
Moreover, a rise in the number of people suffering from leg ulcers may further propel the market growth. For instance, as per NCBI, around 1.5 - 3.0 people in 3,000 have an active leg ulcer at any given point. Similarly, according to the National Health Service, venous leg ulcers are estimated to affect about one in 500 residents in the U.K., thereby boosting the market over the forecast period.
Furthermore, the rising number of surgical procedures is expected to increase the demand for the market. For instance, as per the British Journal of Anaesthesia, approximately 3,102,674 surgical procedures were carried out in the U.K. in the year 2021. Similarly, according to Australian Institute of Health and Welfare, 754,600 patients were admitted for surgery from the public hospital elective surgery waiting list. Thus, the market is expected to grow during the forecast period.
In addition, the number of people suffering from diabetes is increasing year by year. For instance, according to the International Diabetes Federation, the prevalence rate of diabetes among adults in Spain is 14.8%. Moreover, as per the same source, around 537 million people globally have diabetes. The rise in number of diabetes is increasing the risk of diabetic foot ulcers, thereby impelling market growth.
The decline in the COVID-19 population is further anticipated to fuel the growth of the market. Companies in this market are opting for various strategies such as partnerships and distribution agreements to enhance their customer reach during the post COVID-19 period. For instance, in October 2021, Medline launched the Post-Acute Infection Prevention Program. This will be a consultative program that will be focused on post-acute infection prevention. The company will work with the customer to create and provide them with a customized plan regarding best practices for infection control. Moreover, Medline opened 5 new distribution centers in 2021, whereas two more distribution centers are projected for completion in the year 2022. Therefore, such instances are expected to boost the growth of market over the forecast period.